Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India

Oct 26, 2021

Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel,...

Glenmark becomes the first company to launch Remogliflozin + Vildagliptin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India

Dec 29, 2020

Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination (FDC) of...

JMC signs Rs 1,000 cr agreement with FDC in Maldives

Mar 09, 2021

Mumbai (Maharashtra) [India], March 9 : Civil engineering major JMC Projects has signed an agreement with Fahi Dhiriulhun Corporation of the Maldives for the...

Fosfor announces the Fosfor Decision Cloud to Amplify Business Outcomes with AI

Mar 05, 2024

Warren (New Jersey) [US]/ Mumbai (Maharashtra) [India], March 5: Fosfor, a product division of LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and...

Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin + Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in India

Apr 25, 2022

Mumbai (Maharashtra) [India], April 25 (ANI/PR Newswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of...

Alkem launches first time in India FDC of Dapagliflozin, Sitagliptin and Metformin for adults with Type 2 diabetes in India

Oct 06, 2022

Mumbai (Maharashtra) [India], October 6 (ANI/PRNewswire): Alkem Laboratories Limited, the 5th largest Indian pharmaceutical company, has launched for the first time in India, triple...